Monday, April 16, 2018 3:51:12 PM
But I understand the frustration. I just don't understand why now, if Change ended up selling - unless still invested in Cyrcadia and trying to prod them along. I think the problem with the message that started this was the insinuation that a 5-year trial on blood biomarkers would signal the end for iT-Bra technology. At least, that was the impression I got with the post. Then people tried to distinguish the difference and the frustration poured out again. No one likes the confidence in a decision to buy or sell stock being undermined but all of it is risky, especially here in the Pinks.
If five years isn't very long to wait for a trial, I don't think six more months to find out if Cyrcadia is truly making good on its promises is too long either - considering a lot of us have been waiting between 10 and 15 years. Like most of us have said, it's this year or "bust". And all technologies that are helpful for a common cause are welcome - it's not an us or them battle. We're all on the same team.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM